Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes.
Product Description
Common Name | Semaglutide acetate salt | ||
---|---|---|---|
CAS Number | 910463-68-2 | Molecular Weight | 4113.57754 |
Density | N/A | Boiling Point | N/A |
Molecular Formula | C187H291N45O59 | Melting Point | N/A |
MSDS | N/A | Flash Point | N/A |
Molecular Formula | C187H291N45O59 |
---|---|
Molecular Weight | 4113.57754 |
Storage condition | -20°C |
Description | Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes. |
---|---|
Related Catalog |
Signaling Pathways >> GPCR/G Protein >> Glucagon Receptor Research Areas >> Metabolic Disease |
Target |
GLP-1 receptor[1]. |
In Vitro | Semaglutide has two amino acid substitutions compared to human GLP-1 (Aib8, Arg34) and is derivatized at lysine 26. The GLP-1R affinity of Semaglutide is 0.38±0.06 nM[1]. Semaglutide is a GLP-1 analogue with 94% sequence omology to human GLP-1[3. |
In Vivo | The plasma half-life of Semaglutide is 46h in mini-pigs following i.v. administration and semaglutide has an MRT of 63.6h after s.c. dosing to mini-pigs[1]. Semaglutide improves 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced motor impairments. In addition, Semaglutide rescues the decrease of tyrosine hydroxylase (TH) levels, alleviates the inflammation response, reduces lipid peroxidation, inhibits the apoptosis pathway, and also increases autophagy- related protein expression, to protect dopaminergic neurons in the substantia nigra and striatum. Moreover, the long-acting GLP-1 analogue semaglutide is superior to liraglutide in most parameters[2]. Semaglutide lowers blood glucose by stimulating the release of insulin and also lowers body weight[3]. |
Animal Admin | Mice[2] Male C57BL/6 mice 10 weeks old (20-25 g) are used throughout the study. Mice are randomized divided into six groups (n=12 per group) (i) control group treated with saline alone; (ii) liraglutide group treated with saline and liraglutide (25 nmol/kg ip. once daily for 7 days); (iii) Semaglutide group treated with saline and Semaglutide (25 nmol/kg ip. once daily for 7 days), (iv) MPTP group treated with MPTP alone (once daily 20 mg/kg ip. for 7 days); (v) MPTP (once daily 20 mg/kg ip. for 7 days) followed immediately by liraglutide treated group (25 nmol/kg ip. once daily for 7 days). (vi) MPTP (20 mg/kg ip. once daily for 7 days) followed immediately by Semaglutide treated group (25 nmol/kg ip. Once daily for 7 days). At the end of drug treatments, measure the behavioral changes, neuronal damage, inflammatory markers, and other biomarkers[2]. |
References |
[1]. Marso SP, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016 Nov 10;375(19):1834-1844. [2]. Zhang L, et al. Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson's disease mouse model. Neuropeptides. 2018 Oct;71:70-80. [3]. Dhillon S, et al. Semaglutide: First Global Approval. Drugs. 2018 Feb;78(2):275-284. |
CAS: |
Name: |
326-59-0 |
1,3-Benzodioxole-5-aceticacid, methyl ester |
1451-82-7 |
2-Bromo-4'-methylpropiophenone |
79099-07-3 |
N-(tert-Butoxycarbonyl)-4-piperidone |
19099-93-5 |
N-CBZ-4-piperidone |
288573-56-8 |
tert-butyl 4-(4-fluoroanilino)piperidine-1-carboxylate |
23076-35-9 |
Xylazine hydrochloride |
5413-05-8 |
Ethyl 3-oxo-4-phenylbutanoate |
29878-31-7 |
4-METHYL-1H-BENZO[D][1,2,3]TRIAZOLE |
2732926-24-6 |
1H-Benzimidazole-1-ethanamine,N-ethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro- |
20320-59-6 |
Diethyl(phenylacetyl)malonate |
91393-49-6 |
2-(2-chlorophenyl)cyclohexanone |
49851-31-2 |
2-Bromo-1-phenyl-1-pentanone |
102-97-6 |
Benzylisopropylamine |
7361-61-7 |
Xylazine |
110-63-4 |
1,4-Butanediol |
718-08-1 |
Ethyl 3-oxo-4-phenylbutanoate |
54123-15-8 |
Fluclotizolam |
1193389-70-6 |
(4-Fluoro-phenyl)-piperidin-4-yl-amine dihydrochloride |
236117-38-7 |
2-iodo-1-p-tolylpropan-1-one |
80532-66-7 |
methyl-2-methyl-3-phenylglycidate |
28281-49-4 |
3,4-Methylenedioxyphenyl ethyl ketone |
171596-29-5 |
Cialis |
2023788-19-2 |
Tirzepatide |
98977-36-7 |
1-Boc-3-Piperidinone |
66981-73-5 |
Tianeptine |
30123-17-2 |
Tianeptine Sodium Salt |
74163-84-1 |
Troparil |
62-44-2 |
Phenacetin |
69673-92-3 |
2-Chloro-1-(4-Methylphenyl)-1-Propanone |
Exhibition hall:
Q1.Can I have free sample?
A: Yes, free sample avaliable, while the shipping cost should be undertaken by your side.
Q2. How do you ship the goods and how long does it take to arrive?
A: We usually ship by DHL, UPS, FedEx or TNT. It usually takes 3-5 days to arrive. Airline and sea shipping also optional.
Q3.How to proceed an order for your products?
A: Firstly, let us know your requirements or application.
Secondly, we quote according to your requirements or our suggestions.
Thirdly, customer confirms the samples and places deposit for order.
Fourthly, we arrange the production shipping and give you the tracking number.
Q4. Are you trading company or manufacturer?
A: We have many factories and production lines in China. So we can provide wholesale price and steady supply for big orders as the most popular manufacturer.
1. Full experience of large numbers containers loading in Chinese sea port.
2. Fast shipment by reputed shipping line.
3. Packing with pallet as buyer's special request.
4. Best service after shipment with e mail.
5. Cargoes photo before and after loading into container.
6. Raw materials from Chinese origin.
Sign In